VatanicVatanic

CONTACTCONTACT

iPS細胞を動物再生医療の真ん中にまずは犬から。

NEWS

  • 2026.10.26NEWS

    U.S. Patent Allowed for Key Technology for Establishing Animal iPS Cells

    We are pleased to announce that our foundational technology for establishing animal induced pluripotent stem (iPS) cells has received a notice of allowance in the United States, following the grant of the corresponding patent in Japan (U.S. Patent No. 12,781,194).

     

    The patent application was jointly filed by Keio University and Nihon University based on the results of their collaborative research, and Vetanic has obtained an exclusive license to practice the patented technology.

    This notice of allowance confirms that the patentability of our method has been recognised in the United States, following its recognition in Japan. We will continue to pursue patent grants in other countries and regions worldwide.

     

    This patent grant confirms the patentability of this method within Japan. Moving forward, we aim to secure patent approval for this technology in other countries as well.

     

    Technical Details:
    Establishing methods to produce iPS cells from various animal species – a critical resource forming the foundation of cell engineering using stem cells.

    https://www.keio.ac.jp/ja/press-releases/2021/4/2/28-78924